RPAM
Rhenman & Partners Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-200,000
| Closed | -$2.15M | – | 97 |
|
|
2015
Q3 | $2.15M | Buy |
200,000
+29,085
| +17% | +$312K | 0.34% | 77 |
|
|
2015
Q2 | $1.38M | Sell |
170,915
-1,423,890
| -89% | -$458K | 0.17% | 91 |
|
|
2015
Q1 | $1.51M | Hold |
1,594,805
| – | – | 0.25% | 84 |
|
|
2014
Q4 | $1.45M | Buy |
1,594,805
+1,300,000
| +441% | +$1.18M | 0.42% | 78 |
|
|
2014
Q3 | $416K | Hold |
294,805
| – | – | 0.12% | 96 |
|
|
2014
Q2 | $475K | Hold |
294,805
| – | – | 0.14% | 94 |
|
|
2014
Q1 | $510K | Sell |
294,805
-5,195
| -2% | -$8.99K | 0.15% | 89 |
|
|
2013
Q4 | $540K | Buy |
+300,000
| New | +$540K | 0.21% | 79 |
|